Topological distortion and reorganized modular structure of gut microbial co-occurrence networks in inflammatory bowel disease

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Baldassano, Steven N ^a,b   Bassett, Danielle S ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GASTROINTESTINAL TRACT; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; MICROBIOLOGY; PATHOLOGY;

GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; INFLAMMATORY BOWEL DISEASES;

EID: 84970024430     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep26087     Document Type: Article

References (72)

1. Huttenhower, C. Structure, function and diversity of the healthy human microbiome. Nature 486, 207-214 (2012).
2. Cho, I. & Blaser, M. The human microbiome: At the interface of health and disease. Nat Rev Genet 13, 260-270 (2012).
3. Arumugam, M. et al. Enterotypes of the human gut microbiome. Nature 473, 174-180 (2011).
4. Kau, A. L. & Ahern, G. P. P., N. W., Goodman, A. & Gordon, J. Human nutrition, the gut microbiome and the immune system. Nature 474, 327-336 (2011).
5. Zhao, L. The gut microbiota and obesity: from correlation to causality. Nature Rev Microbiol 11, 639-647 (2013).
6. Wen, L. et al. Innate immunity and intestinal microbiota in the development of type 1 diabetes. Nature 455, 1109-1113 (2008).
7. Jostins, L. et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119-124 (2012).
8. Kostic, A., Xavier, R. & Gevers, D. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterol 146, 1489-1499 (2013).
9. Williams, R., Howe, A. & Hofmockel, K. Demonstrating microbial co-occurrence pattern analyses within and between ecosystems. Front Microbiol 5, doi: 10. 3389/fmicb. 2014. 00358 (2014).
10. Eiler, A., Heinrich, F. & Bertilsson, S. Coherent dynamics and association networks among lake bacterioplankton taxa. ISME J 6, 330-342 (2012).
11. Kittelmann, S. et al. Simultaneous amplicon sequencing to explore co-occurrence patterns of bacterial, archaeal and eukaryotic microorganisms in rumen microbial communities. PLoS ONE 8, doi: 10. 1371/journal. pone. 0047879 (2013).
12. Duran-Pinedo, A., Paster, B., Teles, R. & Frias-Lopez, J. Correlation network analysis applied to complex biofilm communities. Plos ONE 6, doi: 10. 1371/journal. pone. 0028438 (2011).
13. Freilich, S. et al. The large-scale organization of the bacterial network of ecological co-occurrence interactions. Nucleic Acids Res 38, 3857-3868 (2010).
14. Faust, K. et al. Microbial co-occurrence relationships in the human microbiome. Plos Comput Biol 8, doi: 10. 1371/journal. pcbi. 1002606 (2012).
15. Borentstein, E. Computational systems biology and in silico modeling of the human microbiome. Brief Bioinform 13, 769-780 (2012).
16. Goodrich, J. et al. Human genetics shape the gut microbiome. Cell 159, 789-799 (2014).
17. Wu, G. et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 334, 105-8 (2011).
18. Levy, R. & Borenstein, E. Metabolic modeling of species interaction in the human microbiome elucidate community-level assembly rules. PNAS 110, 12804-12809 (2013).
19. Tong, M. et al. A modular organization of the human intestinal mucosal microbiota and its association with inflammatory bowel disease. Plos ONE 8, doi: 10. 1371/journal. pone. 0080702 (2013).
20. Milo, R. et al. Network motifs: simple building blocks of complex networks. Science 298, 824-7 (2002).
21. Sartor, R. Therapeutic manipulation of the enteric microflora in inflammatory bowel disease: Antibiotics, probiotics, and prebiotics. Gastroenterol 126, 1620-1633 (2004).
22. Fedorak, R. & Madsen, K. Probiotics and the management of inflammatory bowel disease. Inflamm Bowel Dis 10, 286-299 (2004).
23. Rajilic-Stojanovic, M., Shanahan, F., Guarner, F. & de Vos, W. Phylogenetic analysis of dysbiosis in ulcerative colitis during remission. Inflamm Bowel Dis 19, 481-488 (2013).
24. Everard, A. et al. Cross-talk between akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. PNAS 110, 9066-9071 (2013).
25. Le Chatelier, E. et al. Richness of human gut microbiome correlates with metabolic markers. Nature 500, 541-546 (2013).
26. Kassinen, A. et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterol 133, 24-33 (2007).
27. Brown, K., DeCoffe, D., Molcan, E. & Gibson, D. Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Nutrients 4, 1095-1119 (2012).
28. Philippe, D., Heupel, E., Blum-Sperisen, S. & Riedel, C. Treatment with bifidobacterium bifidum 17 partially protects mice from th1-driven inflammation in a chemically induced model of colitis. Int J Food Microbiol 149, 45-9 (2011).
29. Kim, N., Kunisawa, J., Kweon, M., Eog Ji, G. & Kiyono, H. Oral feeding of bifidobacterium bifidum (bgn4) prevents cd4(+) cd45rb(high) t cell-mediated inflammatory bowel disease by inhibition of disordered t cell activation. Clin Immunol 123, 30-39 (2007).
30. Kleessen, B., Kroesen, A., Buhr, H. & Blaut, M. Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. Scand J Gastroenterol 37, 1034-41 (2002).
31. Sghir, A. et al. Quantification of bacterial groups within human fecal flora by oligonucleotide probe hybridization. Appl Environ Microbiol 66, 2263-6 (2000).
32. Girvan, M. & Newman, E. Community structure in social and biological networks. PNAS 99, 7821-7826 (2002).
33. Good, B., de Montjoye, Y. & Clauset, A. The performance of modularity maximization in practical contexts. Phys Rev E 81, doi: 10. 1103/PhysRevE. 81. 046106 (2010).
34. Schubert, A. et al. Microbiome data distinguish patients with clostridium difficile infection and non-c. difficile-associated diarrhea from healthy controls. mBio 5, doi: 10. 1128/mBio. 01021-14 (2014).
35. Traud, A., Kelsic, E., Mucha, P. & Porter, M. Comparing community structure to characteristic social networks. SIAM Rev 53, 526-543 (2011).
36. Bai, L. et al. Isolation and characterization of cytotoxic, aggregative citrobacter freundii. Plos ONE 7, doi: 10. 1371/journal. pone. 0033054 (2012).
37. Manos, J. & Belas, R. The Genera Proteus, Providencia, and Morganella. The Prokaryotes. Volume 6: Proteobacteria: Gamma Subclass (Springer New York, 2006).
38. Fraga, M., Scavone, P. & Zunino, P. Preventive and therapeutic administration of an indigenous lactobacillus sp. strain against proteus mirabilis ascending urinary tract infection in a mouse model. Antonie van Leeuwenhoek 88, 25-34 (2005).
39. Mackos, A., Eubank, T., Parry, N. & Bailey, M. Probiotic lactobacillus reuteri attenuates the stressor-enhanced severity of citrobacter rodentium infection. Infect Immun 81, 3253-63 (2013).
40. Balish, E. & Warner, T. Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice. Am J Pathol 160, 2253-2257 (2002).
41. Golinska, E. et al. Virulence factors of enterococcus strains isolated from patients with inflammatory bowel disease. World J Gastroenterol 19, 3562-3572 (2013).
42. Wang, S., Hibberd, M., Pettersson, S. & Lee, Y. Enterococcus faecalis from healthy infants modulates inflammation through mapk signaling pathways. Plos ONE 9, doi: 10. 1371/journal. pone. 0097523 (2014).
43. Rashid, T., Ebringer, A. & Wilson, C. The role of klebsiella in crohn's disease with a potential for the use of antimicrobial measures. Int J Rheum Dis 2013, doi: 10. 1155/2013/610393 (2013).
44. Kim, S. et al. Bifidobacterium lactis inhibits nf-kappa-b in intestinal epithelial cells and prevents acute colitis and colitis-associated colon cancer in mice. Inflamm Bowel Dis 16, 1514-25 (2010).
45. Wang, W. et al. Increased proportions of bifidobacterium and the lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel disease. J Clin Microbiol 52, 398-406 (2014).
46. Guimera, R. & Amaral, L. Cartography of complex networks: modules and universal roles. J Stat Mech 2005, doi: 10. 1088/1742-5468/2005/02/P02001 (2005).
47. Colizza, V., Flammini, A., Serrano, A. & Vespignani, A. Detecting rich-club ordering in complex networks. Nat Phys 2, 110-115 (2006).
48. Callaway, D., Newman, M., Strogatz, S. & Watts, D. Network robustness and fragility: Percolation on random graphs. Phys Rev Lett 85, 5468-5471 (2000).
49. Widder, S. et al. Fluvial network organization imprints on microbial co-occurrence networks fluvial network organization imprints on microbial co-occurrence networks. PNAS 111, 12799-12804 (2014).
50. Perua, S., Bertilsson, S., Jones, R. & Eiler, A. Resistant microbial cooccurrence patterns inferred by network topology. Appl Environ Microbiol 81, 2090-2097 (2015).
51. Comte, J., Lovejoy, C., Crevecoeur, S. & Vincent, W. Co-occurrence patterns in aquatic bacterial communities across changing permafrost landscapes. Biogeosciences 13, 175-190 (2015).
52. Solé, R. & Montoya, J. Complexity and fragility in ecological networks. Proc R Soc Lond 268, 2039-2045 (2001).
53. Araújo, M., Rozenfeld, A., Rahbek, C. & Marquet, P. Using species co-occurrence networks to assess the impacts of climate change. Ecography 34, 897-908 (2011).
54. Berry, D. & Widder, S. Deciphering microbial interactions and detecting keystone species with co-occurrence networks. Front Microbiol 5, doi: 10. 3389/fmicb. 2014. 00219 (2014).
55. van den Heuvel, M. & Sporns, O. Rich-club organization of the human connectome. J Neurosci 31, 15775-15786 (2011).
56. Grayson, D. et al. Structural and functional rich club organization of the brain in children and adults. Plos ONE 9, doi: 10. 1371/ journal. pone. 0088297 (2014).
57. Molodecky, N. & Kaplan, G. Environmental risk factors for inflammatory bowel disease. Gastroenterol Hepatol 6, 339-346 (2010).
58. Ungaro, R. et al. Antibiotics associated with increased risk of new-onset crohn's disease but not ulcerative colitis: A meta-analysis. Am J Gastroenterol 109, 1728-1738 (2014).
59. Kronman, M., Zaoutis, T., Haynes, K., Feng, R. & Coffin, S. Antibiotic exposure and ibd development among children: A populationbased cohort study. Pediatrics 130, 794-803 (2012).
60. Hviid, A., Svanstrom, H. & Frisch, M. Antibiotic use and inflammatory bowel diseases in childhood. Gut 60, 49-54 (2011).
61. Rooks, M. et al. Gut microbiome composition and function in experimental colitis during active disease and treatment-induced remission. ISME J 8, 1403-1417 (2014).
62. Morgan, X. et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol 13, doi: 10. 1186/gb-2012-13-9-r79 (2012).
63. Benjamin, J. et al. Smokers with active crohn's disease have a clinically relevant dysbiosis of the gastrointestinal microbiota. Inflamm Bowel Dis 18, 1092-1100 (2012).
64. Gevers, D. et al. The treatment-naive microbiome in new-onset crohn's disease. Cell Host Microbe 15, 382-392 (2014).
65. Qin, J. et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59-65 (2010).
66. Chao, A., Chazdon, R., Colwell, R. & Shen, T. A new statistical approach for assessing similarity of species composition with incidence and abundance data. Ecol Lett 8, 148-159 (2005).
67. Rubinov, M. & Sporns, O. Complex network measures of brain connectivity: Uses and interpretations. NeuroImage 52, 1059-69 (2010).
68. Newman, M. Mathematics of networks., vol. The New Palgrave Encyclopedia of Economics, 2nd edition. (Palgrave Macmillan, Basingstoke, 2008).
69. Perron., O. Zur theorie der matrizen. Math Ann 64, 248-263 (1907).
70. Blondel, V., Guillaume, J., Lambiotte, R. & Lefebvre, E. Fast unfolding of communities in large networks. J Stat Mech Theor Exp 2008, doi: 10. 1088/1742-5468/2008/10/P10008 (2008).
71. Bassett, D. & Bullmore, E. Human brain networks in health and disease. Curr Opin Neurol 22, 340-347 (2009).
72. Bassett, D., Nelson, B., Mueller, B., Camchong, J. & Lim, K. Altered resting state complexity in schizophrenia. Neuroimage 59, 2196-2207 (2012).